Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Comments
Loading...
Sector
Healthcare
Region
US
AUM
93.93M
Fund Score
ProShares Ultra Health Care (ARCA:RXL) Quotes, Forecast and News Summary
ProShares Ultra Health Care (ARCA: RXL) stock price, news, charts, stock research, profile.
| Open | $44.16 |
| High | $44.19 |
| 52 Wk High | $58.74 |
| AUM | 93.93M |
| Dividend | $0.91 |
| Ex-Div Date | Jun 26, 2024 |
| Volume | 2.21K |
| Market Cap | $226.43B |
| Mgmt Fee | 0.75% |
| P/E Ratio | 26.75 |
| Prev. Close | $43.98 |
| Low | $43.81 |
| 52 Wk Low | $42.91 |
| Shares Out | 900.00K |
| Yield | 0.84% |
| Div. Freq | Quarterly |
| Avg. Volume Daily | 2.24K |
| Beta | 1.42 |
| Avg. Expense Ratio | 0.95% |
| P/B Ratio | 4.51 |
Recent News
FAQ
Q
How do I buy ProShares Ultra Health Care (RXL) stock?
A
You can purchase shares of ProShares Ultra Health Care (ARCA:RXL) through any online brokerage.
Q
Who are ProShares Ultra Health Care (RXL) competitors?
A
There are no as such competitors for ProShares Ultra Health Care.
Q
What is the forecast, or price target, for ProShares Ultra Health Care (RXL) stock?
A
There is no analysis for ProShares Ultra Health Care to provide a consensus price target.
Q
What is the current price for ProShares Ultra Health Care (RXL)?
A
The stock price for ProShares Ultra Health Care (ARCA: RXL) is $108.9925 last updated October 10, 2024 at 8:49 AM EDT.
Q
Does ProShares Ultra Health Care (RXL) pay a dividend?
A
A quarterly cash dividend of 0.05 per share of Class A Common Stock. The quarterly cash dividend was payable on October 3, 2018 to stockholders of record on September 26, 2018.
Q
When is ProShares Ultra Health Care (ARCA:RXL) reporting earnings?
A
ProShares Ultra Health Care does not have any upcoming earnings scheduled.
Q
Is ProShares Ultra Health Care (RXL) going to split?
A
There is no upcoming split for ProShares Ultra Health Care.
| Open | $44.16 |
| High | $44.19 |
| 52 Wk High | $58.74 |
| AUM | 93.93M |
| Dividend | $0.91 |
| Ex-Div Date | Jun 26, 2024 |
| Volume | 2.21K |
| Market Cap | $226.43B |
| Mgmt Fee | 0.75% |
| P/E Ratio | 26.75 |
| Prev. Close | $43.98 |
| Low | $43.81 |
| 52 Wk Low | $42.91 |
| Shares Out | 900.00K |
| Yield | 0.84% |
| Div. Freq | Quarterly |
| Avg. Volume Daily | 2.24K |
| Beta | 1.42 |
| Avg. Expense Ratio | 0.95% |
| P/B Ratio | 4.51 |
ETF Details
| Sector | Healthcare |
| Category | Mid Performer-Mid Growth |
| Investment Style | Multi Alternative |
| Fund Inception | Jan 30, 2007 |
| Managers | Tarak Dave Michael Neches |
| Definition | Most of the stocks in this Equity Fund have average financial performance and average growth potential |
Investment Policy
The Fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The Index is constructed and maintained by S&P Dow Jones Indices LLC. The Index includes equity securities of companies from the following GICS industries: health care equipment & supplies, health care providers & services; health care technology; biotechnology; pharmaceuticals; and life sciences tools & services. The Index constituents are weighted using a capped modified market capitalization methodology and rebalanced quarterly.
Popular Channels
Tools & Features
Partners & Contributors
About Benzinga
© 2024 Benzinga | All Rights Reserved